Publicaciones en colaboración con investigadores/as de Hospital Universitari Germans Trias i Pujol (137)

2024

  1. Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications

    Seminars in Thrombosis and Hemostasis, Vol. 50, Núm. 5, pp. 773-789

2023

  1. Cancer-Associated Thrombosis: Trends in Clinical Features, Treatment, and Outcomes From 2001 to 2020

    JACC: CardioOncology, Vol. 5, Núm. 6, pp. 758-772

  2. Feasibility of a screening algorithm for chronic thromboembolic pulmonary hypertension: The OSIRIS study

    Thrombosis Research, Vol. 228, pp. 1-9

  3. Pulmonary Embolism in Patients with COVID-19: Comparison between Different Care Settings

    Seminars in Thrombosis and Hemostasis, Vol. 49, Núm. 1, pp. 34-46

  4. The rationale, design, and methods of a trial to evaluate the efficacy and safety of oxygen therapy in patients with intermediate-risk acute pulmonary embolism

    American Heart Journal, Vol. 257, pp. 62-68

2022

  1. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

    Chest, Vol. 161, Núm. 2, pp. 524-534

  2. Imaging modalities for confirming pulmonary embolism during pregnancy: results from a multicenter international study

    European Radiology, Vol. 32, Núm. 2, pp. 1238-1246

  3. Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism

    Internal and Emergency Medicine, Vol. 17, Núm. 3, pp. 725-734

  4. Major bleeding in patients with pulmonary embolism presenting with syncope

    European journal of clinical investigation, Vol. 52, Núm. 7, pp. e13774

  5. Multidisciplinary Consensus for the Management of Pulmonary Thromboembolism

    Archivos de Bronconeumologia

  6. Predictors of use of direct oral anticoagulants in patients with venous thromboembolism: Findings from the Registro Informatizado Enfermedad Tromboembólica registry

    Frontiers in Medicine, Vol. 9

  7. Prognostic Significance of Findings on CTPA Supporting an Alternative Diagnosis to PE Among Patients Hospitalized for an Exacerbation of COPD: Predefined Subanalysis of the SLICE Trial

    Archivos de Bronconeumologia, Vol. 58, Núm. 5, pp. 412-417

  8. RIETE Registry: Past, Present and Future

    Archivos de Bronconeumologia

  9. Randomised controlled trial of a prognostic assessment and management pathway to reduce the length of hospital stay in normotensive patients with acute pulmonary embolism

    The European respiratory journal, Vol. 59, Núm. 2

  10. Response

    Chest

  11. Sex Differences in PrEsentation, Risk Factors, Drug and Interventional Therapies, and OUtcomes of Elderly PatientS with Pulmonary Embolism: Rationale and design of the SERIOUS-PE study

    Thrombosis Research, Vol. 214, pp. 122-131

  12. Statin use and 30-day mortality in patients with acute symptomatic pulmonary embolism

    Journal of Thrombosis and Haemostasis, Vol. 20, Núm. 8, pp. 1839-1851

2021

  1. Association between preexisting versus newly identified atrial fibrillation and outcomes of patients with acute pulmonary embolism

    Journal of the American Heart Association, Vol. 10, Núm. 17

  2. Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis

    Journal of Thrombosis and Haemostasis, Vol. 19, Núm. 8, pp. 1981-1989

  3. Cerebral Venous Sinus Thrombosis in the U.S. Population, After Adenovirus-Based SARS-CoV-2 Vaccination, and After COVID-19

    Journal of the American College of Cardiology, Vol. 78, Núm. 4, pp. 408-411